Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A patient with complete hair loss regrew all her hair using tofacitinib.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib taken by mouth helps treat hair loss in children.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.